Skip to main content
Home
FDA
  • LOG IN
  • Thompson FDA
  • Manage Account
  •  
  • 1.800.677.3789

Main navigation

  • LIBRARY
    • FDA Enforcement Manual
    • Guide to Good Clinical Practice
    • FDA Advertising and Promotion Manual
    • Guide to Medical Device Regulation
    • Guide to U.S. Food Labeling Law
  • MY RESEARCH
  • NEWS
    • All News
    • FDA Intelligence
  • DATABASES
    • FDA Enforcement Database
    • Clinlaw State Database
  • RESOURCES
    • FDA Forms
    • Special Reports
    • Judicial Opinions
    • Interactive Tools
  • AGENCY GUIDANCE
    • Enforcement Guidance
    • Clinical Trials Guidance
    • Advertising and Promotion Guidance
    • Medical Device Guidance
    • Food Labeling Guidance
  • ASK THE EXPERT

Login to the Thompson
FDA Compliance Expert

Enter your FDA username.
Enter the password that accompanies your username.
Forgot password?

Questions? Give us a call! 1-800-677-3789

Advertising & Promotion

  • Sep 17, 2014
    Nonprofits Ask CMS for Exemption from Open Payments Tracking System
  • Sep 15, 2014
    OMB Clears FDA Study on Effects of Distracting Visuals in DTC Ads
  • Sep 12, 2014
    Justice Dept.: Bayer Ads Violate Court Order
  • Sep 5, 2014
    Medical Groups and Industry Beg CMS Not to Throw Out Baby with Bathwater
  • Sep 3, 2014
    Appellate Panel Revives Shareholder Suit Against Allergan Over Off-label Promotion
  • Aug 27, 2014
    PhRMA Questions Basis for CMS Rejecting One-Third of All Payment Data Submitted
  • Aug 26, 2014
    FTC and FDA Take Aim at Products Claiming To Treat or Prevent Concussions
  • Aug 26, 2014
    Wolfe: Reprint Guidance on Risk Information Will Encourage ‘Off-label Risk Reduction’
  • Aug 18, 2014
    CMS Rejects Roughly a Third of All Payment Records Submitted, Citing Errors in Data
  • Aug 15, 2014
    Open Payments Database Back Up, CMS Declines To Delay Public Rollout
  • More

Good Clinical Practice

  • May 4, 2016
    Algorithm Used To Predict Subject Recruitment
  • May 3, 2016
    HHS To Conduct Title IX Compliance Reviews for University Research Programs
  • May 3, 2016
    CDISC Releases New Registry Standard
  • May 3, 2016
    PRIM&R Responds to ICMJE Data Sharing Proposal
  • May 2, 2016
    Minn. Legislature Passes Bill Affecting University Research
  • May 2, 2016
    NEJM Letter Criticizes Common Rule NPRM
  • Apr 26, 2016
    EMA Issues Guidance on Use of Patient-Reported Outcomes for Oncology Studies
  • Apr 22, 2016
    Public Citizen Wants OHRP and VA To Investigate Kidney Trial
  • Apr 21, 2016
    French Committee Makes Recommendations For First-in-Human and Phase 1 Trials
  • Apr 18, 2016
    Senators Ask for Conflict of Interest Disclosures in PubMed Abstracts
  • More

FDA Regulation & Enforcement

  • Jan 22, 2019
    Study Finds Connection between Opioid Marketing to Physicians and Overdose Deaths
  • Jan 18, 2019
    Washington State Legislators Consider Drug Price Transparency Bills
  • Jan 17, 2019
    New York Attorney General Finds Widespread Seafood Mislabeling
  • Jan 16, 2019
    Citing Federal Preemption, New Jersey Court Dismisses Claims Against Manufacturer of Breast Implant
  • Jan 16, 2019
    FDA Warns Stem Cell Product Companies To Seek Premarket Approvals Before Enforcement Discretion Ends
  • Jan 15, 2019
    House Oversight Committee Gears Up Hearings on Drug Pricing Practices
  • Jan 15, 2019
    AdvaMed Updates Ethics Code on HCP Interactions
  • Jan 11, 2019
    Senators Introduce Bill To Remove Tax Deduction for DTC Drug Advertising
  • Jan 10, 2019
    Drug, Device Companies Paid the Largest Health Care-Related False Claims Recoveries in FY 2018
  • Jan 10, 2019
    Eli Lilly Launches Pricing Website
  • More

THOMPSON FDA

  • Thompson FDA
  • About Us
  • Manage Account
  • Our Parent Company

COMPLIANCE EXPERT

  • News
  • My Research
  • Our Experts
  •  

RESOURCES

  • FDA Forms
  • Special Reports

HELP

  • Customer Support
  •  
  •  
  •  
  •  

CONTACT

  • headquarter Headquarters
  • contact-number 1.800.677.3789
  • Contact Us
  •  

Copyright © Thompson FDA, a division of CBIS. All rights reserved.

  • Terms
  • Privacy

FDA NEWS
YOU CAN USE

Get instant, free access to the latest news and analysis to keep up with the shifting requirements, recommendations, and expectations of the FDA.

Something went wrong. Please try after some time.